Cancer occurrence in Iran in 2002, an international perspective

Asian Pacific Journal of Cancer Prevention

Volumn 6, Issue 3, 2005, Pages 359-363

  Alireza, Sadjadi ^a   Mehdi, Nouraie ^a   Mohammad Ali, Mohagheghi ^b   Alireza, Mousavi Jarrahi ^b   Reza, Malekezadeh ^a   Parkin, Donald Maxwell ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

Author keywords

Cancer incidence; GLOBOCAN; Iran; Population based cancer registries

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INCIDENCE; INFANT; IRAN; MALE; MIDDLE AGED; NEOPLASM; NEWBORN; PRESCHOOL CHILD; REGISTER; STATISTICS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; IRAN; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES;

EID: 32944465417     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Brown LM, Devesa SS (2002). Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am, 11, 235-56.
2. Derakhshan MH, Yazdanbod A, Sadjadi AR, et al (2004). High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. GUT, 53, 1262-6.
3. Farhadi M, Tahmasebi Z, Merat S, et al (2005). Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol, 11, 1200-3.
4. Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide Version 2.0. IARC CancerBase No.5. Lyon, IARC Press.
5. Ferlay J, Bray F, Pisani P, Parkin DM (2001). GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0.IARC CancerBase No. 5. Lyon, IARC Press,
6. Habibi A (1965). Cancer in Iran. A Survey of the most common cases. J Natl Cancer Inst, 34, 553-69.
7. Haghighi P, Nabizadeh I, Asvadi S, Mohallatee EA (1971). Cancer in southern Iran. Cancer, 27, 965-77.
8. Islami F, Kamangar F, Aghcheli K, et al (2004). Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran. Br J Cancer, 90, 1402-6.
9. Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG (1991). Cancer registration principle and methods, International Agency for Research on Cancer, Lyon.
10. Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics. CA Cancer J Clin, 53, 5-26.
11. Kamangar F, Strickland PT, Pourshams A, et al (2005). High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res, 5, 425-8.
12. Lopez AD, Murray CC (1998). The global burden of disease, 1990- 2020. Nat Med, 4, 1241-3.
13. Mahboubi E, Kmet J, Cook PJ, et al (1973). Oesophageal cancer studies in the Caspian Littoral of Iran: the Caspian cancer registry. Br J Cancer, 28, 197-214.
14. Mikaeli J, Malekzadeh R, Ziad-Alizadeh B, et al (2000). Prevalence of Helicobacter pylori in two Iranian provinces with high and low incidence of gastric canrcinoma. Arch Iranian Med, 3, 6-9.
15. Mohagheghi MA, Mosavi-Jarrahi A (2002). The 3rd annual report of Tehran Metropolitan Area Cancer Registry. Tehran, Cancer Institue Research Center. The Cancer Institute Research Center Publicaion.
16. Malekzadeh R, Sotoudeh M, Derakhshan MH, et al (2004). Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. Journal of clinical pathology, 57, 37-42.
17. Noorbala A, Mohammad K (1999). Iran National Health Survey. Tehran, Ministry of Health.
18. Nouarie M, Pourshams A, Kamangar F, et al (2004). Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol, 10, 2544-6.
19. Naghavi M, (2000). Death report from 10 provinces in Iran,Tehran, Ministry of Health.
20. Pourshams A, Saadatian-Elahi M, Nouraie M, et al (2005). Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer, 92, 176-81.
21. Pisani P, Parkin DM, Bray F, Ferlay J (1999). Estimates of the worldwide mortality from twenty-five cancers in 1990. Int J Cancer, 83, 18-29.
22. Sankaranarayanan R, Black RJ, Parkin DM (eds) (1999). Cancer Survival in Developing Countries, IARC Scientific Publications No 145, IARC, Lyon.
23. Sepehr A, Kamangar F, Abnet CC, et al (2004). Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett, 213, 195-202.
24. Parkin DM, Bray FI, Devesa SS (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer, 37 Suppl, S4-66.
25. Pisani P, Bray F, Parkin DM (2002). Estimates of the worldwide prevalence of cancer for twenty-five sites in the adult population. Int J Cancer, 97, 72-81.
26. Statistical Center of Iran (1977). Iran National Census, Tehran, Statistical Center of Iran.
27. Sadjadi A, Malekzadeh R, Derakhshan MH, et al (2003). Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer, 107, 113-8.
28. United Nations (2003). World population prospects. The 2002 Revision. Population database. http://esa.un.org/unpp/).
29. Verdecchia A, Micheli A, Colonna M, et al (2002). A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol, 13, 1128-39.
30. Yazdanbod A, Nasseri-Moghaddam S, Malekzadeh R (2004). Upper gastrointestinal cancer in Ardabil, North-West of Iran. a review. Arch Iranian Med, 7, 173-7.